Details of the Drug Formulations

General Information of Drug (ID: DM7W94S)

Drug Name
Brigatinib Drug Info
Synonyms
1197953-54-0; UNII-HYW8DB273J; Brigatinib [USAN]; ALUNBRIG; HYW8DB273J; Brigatinib (USAN); Brigatiib; Alunbrig (TN); Brigatinib [USAN:INN]; Brigatinib (AP26113); SCHEMBL11916361; KS-00000TSQ; EX-A775; MolPort-044-561-640; BDBM50185140; ZINC148723177; AKOS030257612; CS-4278; DB12267; HY-12857; AC-29958
Indication
Disease Entry ICD 11 Status REF
Anaplastic large cell lymphoma 2A90.A Approved [1]
Non-small-cell lung cancer 2C25.Y Approved [2]
Cross-matching ID
PubChem CID
68165256
CAS Number
1197953-54-0
TTD ID
D08PIE
VARIDT ID
DR00368
INTEDE ID
DR0228
ACDINA ID
D00077

Full List of Drug Formulations Containing This Drug

Brigatinib 180 mg tablet
Company Formulation ID FDA Description
Millennium Pharmaceuticals F02709 Lactose monohydrate; Magnesium stearate; Silicon dioxide; Microcrystalline cellulose; Sodium starch glycolate type a potato
------------------------------------------------------------------------------------
Brigatinib 30 mg tablet
Company Formulation ID FDA Description
Millennium Pharmaceuticals F02710 Lactose monohydrate; Magnesium stearate; Silicon dioxide; Microcrystalline cellulose; Sodium starch glycolate type a potato
ARIAD Pharmaceuticals F02711 Lactose monohydrate; Magnesium stearate; Water; Microcrystalline cellulose; Polyvinyl alcohol, unspecified; Silica dimethyl silylate; Sodium starch glycolate type a potato
------------------------------------------------------------------------------------
Brigatinib 90 mg tablet
Company Formulation ID FDA Description
Millennium Pharmaceuticals F02712 Lactose monohydrate; Magnesium stearate; Silicon dioxide; Microcrystalline cellulose; Sodium starch glycolate type a potato
------------------------------------------------------------------------------------

References

1 2017 FDA drug approvals.Nat Rev Drug Discov. 2018 Feb;17(2):81-85.
2 Drugs@FDA. U.S. Food and Drug Administration. U.S. Department of Health & Human Services. 2018